All Articles

The home care franchise expands to the Golden State, targeting a massive aging population while navigating a complex market and regulatory landscape.

The rail supplier's stellar Q2 results point to surprising strength in coal, rail, and tunneling, but rising costs reveal the challenges of rapid growth.

Promex Industries and QP Technologies appoint David Fromm as President, signaling a strategic push for innovation in critical microelectronics markets.

A new AI platform promises to fix billions in revenue loss from complex cardiac coding, but will it empower or replace human experts in the process?

A new peer-reviewed study shows Glucotrack's fully implantable glucose monitor is accurate for 240 days, a key step towards a 3-year, no-wearable future.

The memory chip maker secures a major defense contract, highlighting the critical role of its MRAM tech and U.S.-based manufacturing for national security.

Medtech titan Brad Saar joins Sonablate's board, signaling a major push to make non-invasive HIFU a global standard for prostate cancer treatment.

The expanded partnership integrates real-time case tracking and post-sale servicing into Hexure's FireLight, aiming to create a single, unified workflow.

Hannover Re US names Kelly Rabin Chief Actuary, a strategic move leveraging her diverse insurtech and consulting background to drive innovation.

Singapore's TechCreate reports 54% revenue growth and a quantum tech leap, but a regulatory trading halt has left investors and the market in the dark.

A new collaboration leverages a vast cord blood bank and advanced AI to create off-the-shelf cell therapies, promising a new era in regenerative medicine.

IEEE-USA is launching BiG Thinkers, a new event uniting leaders from Disney, OpenAI, and Pixar to cultivate creativity and leadership in tech professionals.

Documo’s award-winning AI platform is turning the tide on healthcare's reliance on fax, automating paperwork to reduce staff burnout and improve patient care.

A new report reveals a massive credibility crisis. Retailers invest in sustainability, but a lack of proof has 56% of consumers skeptical.

Alkeus Pharmaceuticals will present crucial data on its oral drug for Stargardt disease, a leading cause of juvenile blindness with no current cure.

The Jewish Theological Seminary appoints engagement expert Rabbi Mike Uram, signaling a strategic shift to modernize and expand its reach in a changing world.

Nashville's Truxton Corporation announces a significant dividend hike, continuing a decade-long trend of rewarding investors fueled by robust financial performance.

BsStrategy's latest platform update signals a major shift in AI finance, where robust infrastructure and risk control are eclipsing the hunt for magic algorithms.

The logistics firm's recognition as a climate leader highlights an industry race where sustainability is now a key competitive and strategic advantage.

PVP Labs' new drug offers potent pain relief without addiction risk. A landmark DEA ruling clears it as a non-controlled substance, set to reshape medicine.